Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Investigation of Platelet Aggregation in Paediatric Patients With Sickle Cell Disease”

3 trials

Showing 3 of 3 results

Testing effectiveness (Phase 2)Study completedNCT02214121
What this trial is testing

A Pharmacokinetic (PK) and Pharmacodynamic (PD) Dose-ranging Phase II Study of Ticagrelor in Paediatric Patients With Sickle Cell Disease

Who this might be right for
Investigation of Platelet Aggregation in Paediatric Patients With Sickle Cell Disease
AstraZeneca 46
Large-scale testing (Phase 3)WithdrawnNCT04293172
What this trial is testing

Study to Evaluate the Effect of Ticagrelor Versus Placebo in Reducing Vaso-Occlusive Crises Rate in Pediatric Patients With Sickle Cell Disease.

Who this might be right for
Sickle Cell Disease
AstraZeneca
Large-scale testing (Phase 3)Ended earlyNCT03615924
What this trial is testing

Effect of Ticagrelor vs. Placebo in the Reduction of Vaso-occlusive Crises in Pediatric Patients With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
AstraZeneca 193

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation